Skip to content

RADX

Radiopharm Theranostics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$0.96
−6.50%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
9.99x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.82x
Price / sales
7.31x
Price / cash flow
-0.37x

Enterprise value

Enterprise value
$9.5M
EV / sales
4.95x
EV / EBITDA
-0.20x
EV / EBIT
-0.19x
Market cap
$14.1M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026